Pharmacist Education for Patient-Centered Diabetes Care
Published Online: Wednesday, May 28, 2014
Starlin Haydon-Greatting, MS, BSPharm, FAPHA, director of clinical programs at the Illinois Pharmacists Association, discusses the training pharmacists should pursue if they are interested in playing a role in patient-centered diabetes care.
This interview was recorded at the American Journal of Managed Care's live meeting on Patient-Centered Diabetes Care, held in Princeton, NJ.
Excess medical costs for diabetes and lost productivity amounted to more than $322 billion in 2012, a 48% increase from the $218 billion estimate for 2007.
Patients with type 2 diabetes mellitus may see a reduction in blood sugar levels and body weight with empagliflozin treatment, according to data from Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals Inc.
Implementing eye screening via telemedicine among patients with diabetes uncovered that 1 in 5 have diabetic retinopathy.